First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers.
Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.
I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...
CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
A woman who lived with three different life-threatening autoimmune diseases for more than a decade has made a “remarkable” ...
CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
Fourteen months after treatment with engineered immune cells, the recipient has no symptoms and doesn’t need to take ...
For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different ...
B-cell acute lymphoblastic leukemia is the most common form of childhood cancer. In this type of cancer, which affects blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results